Cargando…
SDMA attenuates renal tubulointerstitial fibrosis through inhibition of STAT4
BACKGROUND: Renal tubulointerstitial fibrosis is the hallmark of various chronic kidney diseases. Symmetric dimethylarginine (SDMA) is an independent cardiovascular risk factor in patients with chronic kidney diseases, which is mostly excreted through renal tubules. However, the effect of SDMA on ki...
Autores principales: | Wang, Yanzhe, Wu, Ming, Chen, Dongping, Tan, Bo, Lin, Pinglan, Huang, Di, Ye, Chaoyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186707/ https://www.ncbi.nlm.nih.gov/pubmed/37194066 http://dx.doi.org/10.1186/s12967-023-04181-9 |
Ejemplares similares
-
Protein arginine methyltransferase 3 inhibits renal tubulointerstitial fibrosis through asymmetric dimethylarginine
por: Wang, Yanzhe, et al.
Publicado: (2022) -
Salvianolic acid B attenuates tubulointerstitial fibrosis by inhibiting EZH2 to regulate the PTEN/Akt pathway
por: Lin, Pinglan, et al.
Publicado: (2022) -
Remdesivir Inhibits Tubulointerstitial Fibrosis in Obstructed Kidneys
por: Xu, Lin, et al.
Publicado: (2021) -
Renal asymmetric dimethylarginine inhibits fibrosis
por: Wu, Ming, et al.
Publicado: (2020) -
Comparative performance of IDEXX SDMA Test and the DLD SDMA ELISA for the measurement of SDMA in canine and feline serum
por: Ernst, Rie, et al.
Publicado: (2018)